Patrick Donnelly
Stock Analyst at Citigroup
(3.48)
# 869
Out of 5,182 analysts
361
Total ratings
46.88%
Success rate
4.16%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Reinstates: Buy | $60 | $44.28 | +35.50% | 3 | Mar 11, 2026 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $200 → $120 | $114.19 | +5.09% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Buy | $32 → $26 | $13.73 | +89.37% | 5 | Mar 5, 2026 | |
| SHC Sotera Health Company | Maintains: Buy | $21 → $23 | $14.96 | +53.74% | 4 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $135 → $150 | $93.83 | +59.86% | 12 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Neutral | $53 → $40 | $36.76 | +8.81% | 19 | Feb 13, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $23 → $30 | $17.25 | +73.91% | 7 | Feb 12, 2026 | |
| AVTR Avantor | Maintains: Neutral | $13 → $11 | $7.90 | +39.24% | 9 | Feb 12, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $215 | $198.02 | +8.57% | 12 | Feb 10, 2026 | |
| QGEN Qiagen | Maintains: Neutral | $55 → $55 | $41.03 | +34.05% | 15 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $230 → $200 | $173.26 | +15.43% | 14 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $80 | $53.13 | +50.57% | 13 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $660 → $685 | $491.46 | +39.38% | 22 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $265 | $173.89 | +52.40% | 22 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $207.98 | +44.24% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $22.33 | -19.39% | 13 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $21 | $9.44 | +122.58% | 5 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $185 | $115.48 | +60.20% | 27 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,600 → $1,700 | $1,259.94 | +34.93% | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $375 | $279.99 | +33.93% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $375 | $278.25 | +34.77% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $19.29 | +117.73% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $75.65 | +5.75% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $127.38 | -37.20% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $191.12 | +38.66% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $88.94 | +63.03% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $304.24 | -1.39% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.08 | +192.21% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.00 | +37.43% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $273.72 | -5.01% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.58 | -8.81% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $4.75 | +573.68% | 2 | Nov 30, 2018 |
Medline
Mar 11, 2026
Reinstates: Buy
Price Target: $60
Current: $44.28
Upside: +35.50%
ICON Public Limited Company
Mar 11, 2026
Maintains: Neutral
Price Target: $200 → $120
Current: $114.19
Upside: +5.09%
Stevanato Group
Mar 5, 2026
Maintains: Buy
Price Target: $32 → $26
Current: $13.73
Upside: +89.37%
Sotera Health Company
Feb 24, 2026
Maintains: Buy
Price Target: $21 → $23
Current: $14.96
Upside: +53.74%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $135 → $150
Current: $93.83
Upside: +59.86%
Bruker
Feb 13, 2026
Maintains: Neutral
Price Target: $53 → $40
Current: $36.76
Upside: +8.81%
QuidelOrtho
Feb 12, 2026
Maintains: Neutral
Price Target: $23 → $30
Current: $17.25
Upside: +73.91%
Avantor
Feb 12, 2026
Maintains: Neutral
Price Target: $13 → $11
Current: $7.90
Upside: +39.24%
Quest Diagnostics
Feb 10, 2026
Maintains: Neutral
Price Target: $190 → $215
Current: $198.02
Upside: +8.57%
Qiagen
Feb 6, 2026
Maintains: Neutral
Price Target: $55 → $55
Current: $41.03
Upside: +34.05%
Feb 6, 2026
Maintains: Neutral
Price Target: $230 → $200
Current: $173.26
Upside: +15.43%
Feb 5, 2026
Maintains: Buy
Price Target: $70 → $80
Current: $53.13
Upside: +50.57%
Jan 30, 2026
Maintains: Buy
Price Target: $660 → $685
Current: $491.46
Upside: +39.38%
Jan 16, 2026
Maintains: Buy
Price Target: $200 → $265
Current: $173.89
Upside: +52.40%
Jan 7, 2026
Initiates: Buy
Price Target: $300
Current: $207.98
Upside: +44.24%
Dec 11, 2025
Downgrades: Neutral
Price Target: $18
Current: $22.33
Upside: -19.39%
Dec 11, 2025
Upgrades: Buy
Price Target: $12 → $21
Current: $9.44
Upside: +122.58%
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $115.48
Upside: +60.20%
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,259.94
Upside: +34.93%
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $279.99
Upside: +33.93%
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $278.25
Upside: +34.77%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $19.29
Upside: +117.73%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $75.65
Upside: +5.75%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $127.38
Upside: -37.20%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $191.12
Upside: +38.66%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $88.94
Upside: +63.03%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $304.24
Upside: -1.39%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.08
Upside: +192.21%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.00
Upside: +37.43%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $273.72
Upside: -5.01%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.58
Upside: -8.81%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $4.75
Upside: +573.68%